| Last visit was: 18 Sep 2026, 21:05 |
It is currently 18 Sep 2026, 21:05 |
|
|
|
School
|
Status
|
Round
|
Year
|
GMAT
GRE
|
GPA
|
YOE
Years of Experiance
|
Post-MBA industry
|
Location
|
Date
|
|---|---|---|---|---|---|---|---|---|---|
|
SDA Bocconi
Full Time MBA |
Admitted
|
Deadline | 2024 | 670 GMAT Classic 700 GMAT Classic |
4 | 6 | Consulting | India |
25 Apr 2024 11:34 PM
|
|
ESADE
Full Time MBA |
Admitted from WL
|
3rd deadline | 2024 | 670 GMAT Classic 700 GMAT Classic |
4 | 6 | Consulting | India |
25 Apr 2024 11:34 PM
|
|
NUS Singapore
Full Time MBA |
Denied without Interview
|
Round 3 | 2024 | 660 GMAT Classic | 3.6 | 2 | Technology | India |
25 Apr 2024 09:15 PM
|
|
Rotman
Full Time MBA |
Denied with Interview
|
2004 | 660 GMAT Classic | 3.6 | 2 | Technology | India |
25 Apr 2024 09:15 PM
|
|
|
Rotman
Full Time MBA |
Denied with Interview
|
Round 3 | 2024 | 660 GMAT Classic | 3.6 | 2 | Technology | India |
25 Apr 2024 09:14 PM
|
|
Schulich
September Intake |
Admitted, ($)
|
Round 2 | 2024 | 660 GMAT Classic | 3.6 | 2 | Technology | India |
25 Apr 2024 09:13 PM
|
|
Columbia
Full Time MBA |
Matriculating
|
Round 2 | 2024 | 740 GMAT Classic | 3.4 | 6 | Finance: Private Equity | United States |
25 Apr 2024 03:34 PM
|
|
Tepper
Full Time MBA |
Waitlisted without Interview
|
Round 2 | 2024 | 334 GRE | 3.1 | 3 | Healthcare/Pharmaceuticals | India |
25 Apr 2024 12:35 PM
|
|
Stern
Full Time MBA |
Denied without Interview
|
Round 3 | 2024 | 334 GRE | 3.1 | 3 | Healthcare/Pharmaceuticals | India |
25 Apr 2024 12:35 PM
|
|
Rotman
Full Time MBA |
Denied with Interview
|
Round 2 | 2024 | 334 GRE | 3.1 | 3 | Healthcare/Pharmaceuticals | India |
25 Apr 2024 12:35 PM
|
|
Ross (Michigan)
Full Time MBA |
Denied without Interview
|
Round 2 | 2024 | 334 GRE | 3.1 | 3 | Healthcare/Pharmaceuticals | India |
25 Apr 2024 12:35 PM
|
|
Marshall (USC)
Full Time MBA |
Denied without Interview
|
Round 2 | 2024 | 334 GRE | 3.1 | 3 | Healthcare/Pharmaceuticals | India |
25 Apr 2024 12:35 PM
|
|
Kellogg
Full Time MBA |
Denied without Interview
|
Round 2 | 2024 | 334 GRE | 3.1 | 3 | Healthcare/Pharmaceuticals | India |
25 Apr 2024 12:35 PM
|
|
HEC Paris
HEC MiM |
Matriculating
|
2024 | 530 GMAT Classic 720 GMAT Classic |
4 | 1 | Consulting | India |
25 Apr 2024 08:56 AM
|
|
|
INSEAD
INSEAD Master in Management |
Denied without Interview
|
Round 1 | 2025 | 530 GMAT Classic 720 GMAT Classic |
4 | 1 | Consulting | India |
25 Apr 2024 08:55 AM
|
|
Said
Full Time MBA |
Withdrawn Application
|
Round 2 | 2024 | 665 GMAT Focus | 7 | Consulting | India |
25 Apr 2024 03:11 AM
|
|
|
Foster
Full Time MBA |
Admitted, ($$)
|
Round 1 | 2024 | 5 | Technology | Thailand |
24 Apr 2024 07:11 PM
|
||
|
McCombs
Full Time MBA |
Admitted, ($$)
|
Round 1 | 2024 | 5 | Technology | Thailand |
24 Apr 2024 07:11 PM
|
||
|
Marshall (USC)
Full Time MBA |
Admitted, ($$)
|
Round 1 | 2024 | 5 | Technology | Thailand |
24 Apr 2024 07:11 PM
|
||
|
Anderson
Full Time MBA |
Waitlisted with Interview
|
Round 1 | 2024 | 5 | Technology | Thailand |
24 Apr 2024 07:11 PM
|